Surgeon Sex and Long-Term Postoperative Outcomes Among Patients Undergoing Common Surgeries.


Journal

JAMA surgery
ISSN: 2168-6262
Titre abrégé: JAMA Surg
Pays: United States
ID NLM: 101589553

Informations de publication

Date de publication:
01 Nov 2023
Historique:
pmc-release: 30 08 2024
medline: 9 11 2023
pubmed: 30 8 2023
entrez: 30 8 2023
Statut: ppublish

Résumé

Sex- and gender-based differences in a surgeon's medical practice and communication may be factors in patients' perioperative outcomes. Patients treated by female surgeons have improved 30-day outcomes. However, whether these outcomes persist over longer follow-up has not been assessed. To examine whether surgeon sex is associated with 90-day and 1-year outcomes among patients undergoing common surgeries. A population-based retrospective cohort study was conducted in adults in Ontario, Canada, undergoing 1 of 25 common elective or emergent surgeries between January 1, 2007, and December 31, 2019. Analysis was performed between July 15 and October 20, 2022. Surgeon sex. An adverse postoperative event, defined as the composite of death, readmission, or complication, was assessed at 90 days and 1 year following surgery. Secondarily, each of these outcomes was assessed individually. Outcomes were compared between patients treated by female and male surgeons using generalized estimating equations with clustering at the level of the surgical procedure, accounting for patient-, procedure-, surgeon-, anesthesiologist-, and facility-level covariates. Among 1 165 711 included patients, 151 054 were treated by a female and 1 014 657 by a male surgeon. Overall, 14.3% of the patients had 1 or more adverse postoperative outcomes at 90 days and 25.0% had 1 or more adverse postoperative outcomes 1 year following surgery. Among these, 2.0% of patients died within 90 days and 4.3% died within 1 year. Multivariable-adjusted rates of the composite end point were higher among patients treated by male than female surgeons at both 90 days (13.9% vs 12.5%; adjusted odds ratio [AOR], 1.08; 95% CI, 1.03-1.13) and 1 year (25.0% vs 20.7%; AOR, 1.06; 95% CI, 1.01-1.12). Similar patterns were observed for mortality at 90 days (0.8% vs 0.5%; AOR 1.25; 95% CI, 1.12-1.39) and 1 year (2.4% vs 1.6%; AOR, 1.24; 95% CI, 1.13-1.36). After accounting for patient, procedure, surgeon, anesthesiologist, and hospital characteristics, the findings of this cohort study suggest that patients treated by female surgeons have lower rates of adverse postoperative outcomes including death at 90 days and 1 year after surgery compared with those treated by male surgeons. These findings further support differences in patient outcomes based on physician sex that warrant deeper study regarding underlying causes and potential solutions.

Identifiants

pubmed: 37647075
pii: 2808894
doi: 10.1001/jamasurg.2023.3744
pmc: PMC10469289
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1185-1194

Auteurs

Christopher J D Wallis (CJD)

Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Division of Urology, Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada.
Department of Surgical Oncology, University Health Network, Toronto, Ontario, Canada.

Angela Jerath (A)

Department of Anesthesia, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.

Khatereh Aminoltejari (K)

Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

Kirusanthy Kaneshwaran (K)

Department of Anesthesia, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.

Arghavan Salles (A)

Department of Medicine, Stanford University School of Medicine, Palo Alto, California.

Natalie Coburn (N)

Department of Surgery, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.

Frances C Wright (FC)

Department of Surgery, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.

Lesley Gotlib Conn (L)

Department of Surgery, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.

Zachary Klaassen (Z)

Division of Urology, Medical College of Georgia-Augusta University, Augusta.

Amy N Luckenbaugh (AN)

Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.

Sanjana Ranganathan (S)

Division of Plastic Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

Carlos Riveros (C)

Division of Plastic Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

Colin McCartney (C)

Department of Anesthesia, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.

Kathleen Armstrong (K)

Division of Plastic Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

Barbara Bass (B)

George Washington University, School of Medicine and Health Sciences, Washington, DC.

Allan S Detsky (AS)

Department of Medicine, Mount Sinai Hospital and University Health Network, Toronto, Ontario, Canada.
Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Raj Satkunasivam (R)

Department of Urology, Houston Methodist Hospital, Houston, Texas.
Center for Outcomes Research, Houston Methodist Hospital, Houston, Texas.
Department of Health Policy and Management, School of Public Health, Texas A&M University, College Station.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH